These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7914079)

  • 1. Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia.
    Hattori M; Nanko S; Dai XY; Fukuda R; Kazamatsuri H
    Biochem Biophys Res Commun; 1994 Jul; 202(2):757-63. PubMed ID: 7914079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).
    Itokawa M; Arinami T; Futamura N; Hamaguchi H; Toru M
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1369-75. PubMed ID: 7902708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the dopamine D2 receptor gene].
    Arinami T; Itokawa M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):129-37. PubMed ID: 7941777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism.
    Higuchi S; Muramatsu T; Murayama M; Hayashida M
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1199-205. PubMed ID: 7980596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients.
    Chen CH; Chien SH; Hwu HG
    Am J Med Genet; 1996 Jul; 67(4):418-20. PubMed ID: 8837714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ser9Gly polymorphism in the dopamine D3 receptor gene is not associated with essential hypertension in the Japanese.
    Soma M; Nakayama K; Rahmutula D; Uwabo J; Sato M; Kunimoto M; Aoi N; Kosuge K; Kanmatsuse K
    Med Sci Monit; 2002 Jan; 8(1):CR1-4. PubMed ID: 11796958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia.
    Tanaka T; Igarashi S; Onodera O; Tanaka H; Fukushima N; Takahashi M; Kameda K; Tsuji S; Ihda S
    Am J Med Genet; 1996 Apr; 67(2):208-11. PubMed ID: 8723049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia.
    Ohara K; Nakamura Y; Xie DW; Ishigaki T; Deng ZL; Tani K; Zhang HY; Kondo N; Liu JC; Miyasato K; Ohara K
    Biol Psychiatry; 1996 Dec; 40(12):1209-17. PubMed ID: 8959285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two polymorphisms within interleukin-3 (hIL3) gene detected by mismatch PCR/RFLP.
    Nakashima H; Otsuka T; Ohba Y; Akahoshi M; Nagano S; Ogami E; Arinobu Y; Miyake K; Inoue Y; Niiro H; Kaji Y; Niho Y
    Genes Immun; 1999 Nov; 1(2):156-8. PubMed ID: 11196663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study between schizophrenia and dopamine D3 receptor gene polymorphism.
    Tanaka T; Igarashi S; Onodera O; Tanaka H; Takahashi M; Maeda M; Kameda K; Tsuji S; Ihda S
    Am J Med Genet; 1996 Jul; 67(4):366-8. PubMed ID: 8837704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotyping the -521C/T functional polymorphism in the promoter region of dopamine D4 receptor (DRD4) gene.
    Ronai Z; Barta C; Guttman A; Lakatos K; Gervai J; Staub M; Sasvari-Szekely M
    Electrophoresis; 2001 Apr; 22(6):1102-5. PubMed ID: 11358133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia.
    Griffon N; Crocq MA; Pilon C; Martres MP; Mayerova A; Uyanik G; Burgert E; Duval F; Macher JP; Javoy-Agid F; Tamminga CA; Schwartz JC; Sokoloff P
    Am J Med Genet; 1996 Feb; 67(1):63-70. PubMed ID: 8678117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Associations between six functional genes and schizophrenia].
    Zhang ML; Yuan GZ; Yao JJ; Qian YC; Zhang X; Huang YP; Tang RC; Ji Q; Jiang SD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):69-71. PubMed ID: 12579508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Taq IA and Ser311 Cys polymorphisms in the dopamine D2 receptor gene and obesity.
    Southon A; Walder K; Sanigorski AM; Zimmet P; Nicholson GC; Kotowicz MA; Collier G
    Diabetes Nutr Metab; 2003 Feb; 16(1):72-6. PubMed ID: 12848308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical note: DNA typing for ovine MHC DRB1 using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
    Konnai S; Nagaoka Y; Takesima S; Onuma M; Aida Y
    J Dairy Sci; 2003 Oct; 86(10):3362-5. PubMed ID: 14594256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia.
    Lee HS; Kim SH; Lee HJ; Kim L; Lee SK; Jang DW; Lee MS; Son BG; Suh KY; Kim S
    Am J Med Genet; 2002 Aug; 114(6):593-7. PubMed ID: 12210271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia.
    Mant R; Williams J; Asherson P; Parfitt E; McGuffin P; Owen MJ
    Am J Med Genet; 1994 Mar; 54(1):21-6. PubMed ID: 7909989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between different psychotic disorders and the DRD4 polymorphism, but no differences in the main ligand binding region of the DRD4 receptor protein compared to controls.
    Weiss J; Mägert HJ; Cieslak A; Forssmann WG
    Eur J Med Res; 1996 Jun; 1(9):439-45. PubMed ID: 9353244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of association of D3 dopamine receptor MscI polymorphism with schizophrenia: analysis of symptom ratings, family history, age at onset, and movement disorders.
    Gaitonde EJ; Morris A; Sivagnanasundaram S; McKenna PJ; Hunt DM; Mollon JD
    Am J Med Genet; 1996 Sep; 67(5):455-8. PubMed ID: 8886161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.